Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Filings indexed 636 across all filing types
Latest filing 2023-02-23 Earnings Release
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
230223_biocartis_fy22_results_pr_eng_final.pdf
Earnings Release Classification · 100% confidence The document is explicitly titled "BIOCARTIS ANNOUNCES 2022 RESULTS AND 2023 OUTLOOK" and contains detailed financial metrics (Total operating income, Product revenue, Gross profit, Operating cash burn) and forward-looking guidance for 2023. This content structure is characteristic of a periodic financial results announcement, specifically for a full year (2022 results). The document mentions hosting a conference call to discuss these results, which is typical for an Earnings Release (ER) or a comprehensive report. Given the depth of the financial data provided (not just highlights, but detailed revenue breakdowns, margin changes, and cash burn figures), it goes beyond a simple Earnings Release (ER) but is not explicitly labeled as a 10-K. Since it covers the full year's performance and includes management commentary and outlook, it aligns best with the comprehensive nature of an Annual Report (10-K) or a detailed Interim/Quarterly Report (IR). However, since it covers the full year and is a comprehensive announcement of results, it is most closely aligned with the content expected in an Annual Report context, even if it is presented as a press release. If it were a full 10-K filing, the structure would be more formal. Since it is a detailed announcement of full-year results, 'ER' (Earnings Release) is often used for the initial announcement, but the detail here suggests a more comprehensive document. Given the options, and the fact that it details the *full year* results, it is a strong candidate for an Earnings Release (ER) which often contains substantial detail when issued as a press release, or potentially an Interim Report (IR) if the company typically files IRs instead of 10-Ks for annual summaries, but 'ER' is the most fitting for a results announcement press release. Since it covers the full year, it is more comprehensive than a typical quarterly ER, but less formal than a 10-K. I will classify it as an Earnings Release (ER) as it is a press release announcing the results and outlook, which is the primary function here. FY 2022
2023-02-23 English
230223_biocartis_fy22_results_pr_nl_final.pdf
Earnings Release Classification · 99% confidence The document is titled "BIOCARTIS MAAKT RESULTATEN 2022 EN VOORUITZICHTEN 2023 BEKEND" (Biocartis Announces 2022 Results and 2023 Outlook). It contains detailed financial figures for the full year 2022 (Total revenues, Gross profit, Operating cash burn) and provides specific financial guidance (forecasts) for 2023. This structure—a comprehensive review of past performance and forward-looking statements—is characteristic of an Earnings Release (ER) or a more detailed Management Discussion and Analysis (MDA). Since it includes detailed financial tables and management commentary on results and outlook, it goes beyond a simple 'key highlights only' Earnings Release (ER). It strongly aligns with the description of a Management Reports (MDA), which covers detailed explanation of financial results, business trends, and outlook. Although it is a press release announcing the results, the content depth suggests it is the primary document detailing the results, rather than just a short announcement of publication (RPA). Given the comprehensive nature of the results and outlook, MDA is the most appropriate classification, although ER is a close second if the document were shorter or less detailed. FY 2022
2023-02-23 Dutch
230131 PR Outstanding shares_Jan2023_ENG_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly titled "PRESS RELEASE REGULATED INFORMATION" and its primary content is the "Disclosure of Outstanding Voting Securities" as of January 31, 2023. It details the issuance of new shares against debt contribution and updates the total outstanding share capital, voting securities, and potential future issuances based on options and convertible bonds. This type of mandatory disclosure regarding changes in the total number of voting rights, often triggered by specific events like share issuance or debt conversion, falls under regulations concerning major shareholdings or capital structure changes. Since it is a formal announcement updating the total number of voting rights (which directly relates to share ownership thresholds), it aligns best with either a general regulatory filing (RNS) or a notification related to share capital changes (SHA). However, the core purpose is to disclose the current total voting rights count, which is a specific regulatory requirement often linked to major shareholding rules (as cited: Belgian Act of 2 May 2007). Given the options, this is a specific regulatory disclosure about the total share count and voting rights, which is a fundamental aspect of share capital structure. It is not a general earnings release (ER), an interim report (IR), or a proxy statement (PSI). It is a specific disclosure about the capital structure and voting rights, making 'Share Issue/Capital Change' (SHA) a strong candidate, as the disclosure is triggered by a share issuance. Alternatively, since it is a formal, regulated press release updating mandatory disclosure figures, 'Regulatory Filings' (RNS) is also plausible as a fallback. Given the explicit focus on updating the total outstanding voting securities following a share issuance, SHA is more precise than the general RNS category. The document is a full disclosure, not just an announcement of a report (RPA).
2023-01-31 English
230131 PR Outstanding shares_Jan2023_NL_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Press Release Regulated Information) and is dated January 31, 2023. The core content is an announcement regarding the 'Openbaarmaking van uitstaande stemrechtverlenende effecten' (Disclosure of outstanding voting securities). Specifically, it details the issuance of new shares in exchange for debt settlement (in-kind contribution) and updates the total outstanding capital, voting rights, and potential future issuances from options and convertible bonds. This type of mandatory disclosure, which updates the total number of shares and voting rights as required by local market regulations (mentioning the Belgian Law of May 2, 2007, and the FSMA), fits best under the category of a general regulatory announcement or a specific capital/share change notification. Since it explicitly details the change in the number of shares outstanding due to a debt-for-equity swap and updates the total share count, it strongly relates to 'Share Issue/Capital Change' (SHA). However, the document is structured as a formal press release announcing a regulatory update concerning share capital structure, which is often categorized as a general regulatory filing if a more specific code doesn't perfectly capture the context of mandatory disclosure of voting rights changes. Given the detailed breakdown of share counts and the nature of the announcement (debt conversion leading to new shares), 'SHA' (Share Issue/Capital Change) is highly relevant. Alternatively, since it is a mandatory disclosure of voting rights changes, it could be seen as a general regulatory filing (RNS). Because the primary event described is the issuance of new shares via debt conversion, SHA is the most precise fit among the specific codes related to capital structure changes. The document is a full announcement, not just a notice that a report is attached, so RPA/RNS as a fallback for short announcements is not triggered.
2023-01-31 Dutch
Transp Notif Heights_CVI_1Dec2022.pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Transparency notification Form TR-1 BE' issued by the 'FINANCIAL SERVICES AND MARKETS AUTHORITY (FSMA)'. Section 3 indicates the reason for notification is 'Acquisition or disposal of voting securities or voting rights'. Section 10 details the 'Notified details' regarding 'Voting rights' before and after a transaction, specifically mentioning changes in holdings by entities like 'Heights Capital Management, Inc.' and 'CVI Investments. Inc.'. This structure is characteristic of a mandatory disclosure filing related to changes in significant share ownership or voting rights thresholds. This aligns precisely with the definition for Major Shareholding Notification (MRQ).
2023-01-04 English
TranspNotif Heights_CVI_5Dec2022.pdf
Major Shareholding Notification Classification · 98% confidence The document text clearly shows a structured form titled 'Form TR-1 BE' under the header 'FSMA MARKETS AUTHORITY'. Section 3 indicates the reason for notification is 'Acquisition or disposal of voting securities or voting rights'. Section 10 details the 'Notified details' regarding voting rights before and after a transaction, showing specific numbers of rights and percentages. This structure and content are characteristic of a Major Shareholding Notification, specifically reporting a change in ownership that crosses a threshold, which aligns with the definition for 'Major Shareholding Notification' (MRQ). Although Form TR-1 is a European transparency directive form, in the context of the provided classification codes, MRQ is the closest fit for reporting changes in significant share ownership.
2023-01-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.